Mutation screening of the neurexin 1 gene in thai patients with intellectual disability and autism spectrum disorder

Genetic Testing and Molecular Biomarkers

Volumn 18, Issue 7, 2014, Pages 510-515

  Yangngam, Supaporn ^a,b   Plong On, Oradawan ^b   Sripo, Thanya ^b   Roongpraiwan, Rawiwan ^c   Hansakunachai, Tippawan ^d   Wirojanan, Juthamas ^a   Sombuntham, Tasnawat ^c   Ruangdaraganon, Nichara ^c   Limprasert, Pornprot ^b  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

^d THAMMASAT UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

5' UNTRANSLATED REGION; ADOLESCENT; ALPHA NEUREXIN GENE; ARTICLE; AUTISM; BETA NEUREXIN GENE; CHILD; CONTROLLED STUDY; DNA SEQUENCE; DSM-IV; EXON; FEMALE; GENE; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; INTELLECTUAL IMPAIRMENT; INTRON; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NEUREXIN 1 GENE; POLYMERASE CHAIN REACTION; PROTEIN FUNCTION; PROTEIN SECONDARY STRUCTURE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STANFORD-BINET INTELLIGENCE SCALE; THAI (PEOPLE); COMPLICATION; GENETIC MARKER; GENETICS; MUTATION; THAILAND;

GENETIC MARKER; NERVE CELL ADHESION MOLECULE; NERVE PROTEIN; NRXN1 PROTEIN, HUMAN;

CELL ADHESION MOLECULES, NEURONAL; CHILD DEVELOPMENT DISORDERS, PERVASIVE; GENETIC MARKERS; GENETIC TESTING; HUMANS; INTELLECTUAL DISABILITY; MUTATION; NERVE TISSUE PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; THAILAND;

EID: 84904279820     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2014.0003     Document Type: Article

References (22)

1. Bena F, Bruno DL, Eriksson M, et al. (2013) Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature. Am J Med Genet B Neuropsychiatr Genet 162B:388-403.
2. Camacho-Garcia RJ, Planelles MI, Margalef M, et al. (2012) Mutations affecting synaptic levels of neurexin-1beta in autism and mental retardation. Neurobiol Dis 47:135-143.
3. Comoletti D, Miller MT, Jeffries CM, et al. (2010) The mac-romolecular architecture of extracellular domain of alpha NRXN1: domain organization, flexibility, and insights into trans-synaptic disposition. Structure 18:1044-1053.
4. Dabell MP, Rosenfeld JA, Bader P, et al. (2013) Investigation of NRXN1 deletions: clinical and molecular characterization. Am J Med Genet A 161A:717-731.
5. Ding D, Xu L, Menon M, et al. (2005) Effect of GGC (glycine) repeat length polymorphism in the human androgen receptor on androgen action. Prostate 62:133-139. (Pubitemid 40096779)
6. Feng J, Schroer R, Yan J, et al. (2006) High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neurosci Lett 409:10-13. (Pubitemid 44585112)
7. Gauthier J, Siddiqui TJ, Huashan P, et al. (2011) Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet 130:563-573.
8. Jamain S, Quach H, Betancur C, et al. (2003) Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 34:27-29. (Pubitemid 36548785)
9. Kim HG, Kishikawa S, Higgins AW, et al. (2008) Disruption of neurexin 1 associated with autism spectrum disorder. Am J Hum Genet 82:199-207. (Pubitemid 351735950)
10. Laumonnier F, Bonnet-Brilhault F, Gomot M, et al. (2004) X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet 74:552-557. (Pubitemid 38325925)
11. Liu Y, Hu Z, Xun G, et al. (2012) Mutation analysis of the NRXN1 gene in a Chinese autism cohort. J Psychiatr Res 46:630-634.
12. Miles JH, McCathren RB, Stichter J, et al. (2010) Autism spectrum disorders. In: Pagon RA, Adam MP, Bird TD et al. (eds) GeneReviews™. Available at www.ncbi.nlm.nih.gov/books/NBK1442/, accessed September 20 2013.
13. Miller DT, Adam MP, Aradhya S, et al. (2010) Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 86: 749-764.
14. Miller MT, Mileni M, Comoletti D, et al. (2011) The crystal structure of the alpha-neurexin-1 extracellular region reveals a hinge point for mediating synaptic adhesion and function. Structure 19:767-778.
15. Mikhailov A, Fennell A, Plong-On O, et al. (2014) Screening of NLGN3 and NLGN4X genes in Thai children with autism spectrum disorder. Psychiatr Genet 24:42-43.
16. Rowen L, Young J, Birditt B, et al. (2002) Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. Genomics 79:587-597. (Pubitemid 34274301)
17. Schaaf CP, Boone PM, Sampath S, et al. (2012) Phenotypic spectrum and genotype-phenotype correlations of NRXN1 exon deletions. Eur J Hum Genet 20:1240-1247.
18. Schaaf CP, Sabo A, Sakai Y, et al. (2011) Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders. Hum Mol Genet 20:3366-3375.
19. Tabuchi K, Sudhof TC (2002) Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. Genomics 79:849-859. (Pubitemid 34595320)
20. Yan J, Noltner K, Feng J, et al. (2008) Neurexin 1alpha structural variants associated with autism. Neurosci Lett 438: 368-370.
21. Ye H, Liu J, Wu JY (2010) Cell adhesion molecules and their involvement in autism spectrum disorder. Neurosignals 18:62-71.
22. Zweier C, de Jong EK, Zweier M, et al. (2009) CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila. Am J Hum Genet 85: 655-666.